Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | GAA | P10253 | 7/20 | 0.46 |
| ▸ | HTT | P42858 | 2/20 | 0.41 |
| ▸ | MAOB | P27338 | 3/20 | 0.41 |
| ▸ | MAOA | P21397 | 2/20 | 0.41 |
| ▸ | ACHE | P22303 | 1/20 | 0.39 |
| ▸ | PKM | P14618 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL994414 | 0.91 | KMT2A (0.47) | KMT2AMEN1GAAHTTMAOB | |
| SCHEMBL4951288 | 0.89 | MAOB (0.44) | KMT2AMEN1GAAHTTMAOB | |
| SCHEMBL8880154 | 0.88 | KMT2A (0.46) | KMT2AMEN1GAAHTTMAOB | |
| SCHEMBL11449728 | 0.87 | KMT2A (0.45) | KMT2AMEN1GAAHTTMAOB | |
| SCHEMBL10575745 | 0.87 | KMT2A (0.45) | KMT2AMEN1GAAHTTMAOB | |
| SCHEMBL11449678 | 0.86 | KMT2A (0.44) | KMT2AMEN1GAAHTTMAOB | |
| SCHEMBL11449677 | 0.86 | KMT2A (0.44) | KMT2AMEN1GAAHTTMAOB | |
| SCHEMBL10926757 | 0.86 | GAA (0.46) | KMT2AMEN1GAAHTTMAOB | |
| SCHEMBL9382349 | 0.86 | GAA (0.46) | KMT2AMEN1GAAHTTMAOB | |
| SCHEMBL10348415 | 0.86 | GAA (0.46) | KMT2AMEN1GAAHTTMAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 246 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1885787-B1 | PHOSPHITE ADDITIVES IN POLYOLEFINS | PHILLIPS PETROLEUM CO (US) | 2018-01-10 | — | — | EP | claimed |
| EP-1885787-A1 | PHOSPHITE ADDITIVES IN POLYOLEFINS | Philips Petroleum Company (US) | 2008-02-13 | — | — | EP | claimed |
| US-7157511-B2 | Phosphite additives in polyolefins | CHEVRON PHILLIPSCHEMICAL COMPANY LP | 2007-01-02 | — | — | US | claimed |
| WO-2006124018-A1 | PHOSPHITE ADDITIVES IN POLYOLEFINS | PHILLIPS PETROLEUM COMPANY (US) | 2006-11-23 | — | — | WO | claimed |
| US-20050113494-A1 | Phosphite additives in polyolefins | THE HUNTINGTON NATIONAL BANK | 2005-05-26 | — | — | US | claimed |
| EP-0818526-B1 | Stabilizers for the prevention of gum formation in gasoline | CIBA SC HOLDING AG (CH) | 2003-02-12 | — | — | EP | claimed |
| US-5711767-A | AMINES, PHENOLIC COMPOUNDS AND NITROXIDE | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 1998-01-27 | — | — | US | claimed |
| EP-0818526-A1 | Stabilizers for the prevention of gum formation in gasoline | Ciba SC Holding AG (CH) | 1998-01-14 | — | — | EP | claimed |
| US-5006577-A | Durable, weatherproof | CIBA-GEIGY CORPORATION (US) | 1991-04-09 | — | — | US | claimed |
| EP-4747310-A1 | NON-FLUORINATED POLYMER PROCESSING AIDS FOR DIE LIP BUILD-UP MITIGATION IN EXTRUSION OF COMPOSITIONS CONTAINING RECYCLED POLYETHYLENE | Nova Chemicals (International) S.A. (CH) | 2026-05-27 | — | — | EP | disclosed |
| EP-4536463-B1 | PROCESS TO PREPARE THERMOPLASTIC COMPOSITIONS COMPRISING FLUORINE FREE POLYMER PROCESSING AIDS | NOVA CHEMICALS INTERNATIONAL SA (CH) | 2026-05-13 | — | — | EP | disclosed |
| EP-4731708-A1 | POLAR POLYMERS AS PROCESSING AIDS IN POLYETHYLENE | Nova Chemicals (International) S.A. (CH) | 2026-04-29 | — | — | EP | disclosed |
| EP-4728007-A1 | NON-FLUORINATED POLYMER PROCESS AIDS | Nova Chemicals (International) S.A. (CH) | 2026-04-22 | — | — | EP | disclosed |
| US-20260070275-A1 | FLUOROPOLYMER FREE POLYMER PROCESSING AIDS | NOVA CHEMICALS (INTERNATIONAL) S.A. (CH) | 2026-03-12 | — | — | US | disclosed |
| US-5006577-A | Durable, weatherproof | CIBA-GEIGY CORPORATION (US) | 1991-04-09 | — | — | US | disclosed |
| US-5004770-A | Light, heat, and oxygen resistant | CIBA-GEIGY CORPORATION (US) | 1991-04-02 | — | — | US | disclosed |
| EP-0356687-A1 | Bis (tri-tertiary-alkylphenoxy) diphosphaspiroundecanes | GE SPECIALTY CHEMICALS, INC. (US) | 1990-03-07 | — | — | EP | disclosed |
| EP-0356688-A2 | 3, 9-diphosphaspiroundecanes and process for making 3, 9-diphosphaspiroundecanes | GE SPECIALTY CHEMICALS, INC. (US) | 1990-03-07 | — | — | EP | disclosed |
| EP-0309401-A1 | Stabilization of coatings with N-hydroxy hindered amines | CIBA-GEIGY AG (CH) | 1989-03-29 | — | — | EP | disclosed |
| US-4691015-A | STABILIZERS | CIBA-GEIGY CORPORATION (US) | 1987-09-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260070275-A1 | FLUOROPOLYMER FREE POLYMER PROCESSING AIDS | PFKP, LCP1, PIGK | KMT2A 3449/4885MEN1 3378/4885GAA 498/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.